Mutations in known genes (BRCA1, BRCA2, TP53, CHEK2, PTEN, and ATM) explain only 20–25% of the familial clustering of breast cancer; the residual familial clustering may be explained by the existence of multiple common, low-penetrance alleles (‘polygenes’) [25]. This evidence concerns the gene BRCA1 and breast carcinoma.